Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Evommune Inc. (EVMN) had Free Cash Flow per Share of $-12.49 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$13.00M |
|
$-68.87M |
|
-- |
|
$13.00M |
|
$94.07M |
|
$-81.07M |
|
$12.20M |
|
$-68.87M |
|
$-68.87M |
|
$-68.87M |
|
$-68.87M |
|
$-68.87M |
|
$-68.87M |
|
$-81.07M |
|
$-79.68M |
|
6.14M |
|
6.14M |
|
$-11.22 |
|
$-11.22 |
|
| Balance Sheet Financials | |
$153.48M |
|
$0.99M |
|
$71.47M |
|
$224.95M |
|
$17.91M |
|
$0.18M |
|
$1.47M |
|
$19.38M |
|
$205.57M |
|
$205.57M |
|
$205.57M |
|
31.52M |
|
| Cash Flow Statement Financials | |
$-76.44M |
|
$-115.31M |
|
$220.76M |
|
$16.46M |
|
$45.48M |
|
$29.02M |
|
$5.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.57 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-623.62% |
|
-623.62% |
|
-612.94% |
|
-529.77% |
|
-529.77% |
|
$-76.68M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-33.50% |
|
-33.50% |
|
-30.62% |
|
-33.47% |
|
$6.52 |
|
|
Free Cash Flow per Share |
$-12.49 |
$-12.46 |
|